CD4-Pseudomonas exotoxin hybrid protein blocks the spread of human immunodeficiency virus infection in vitro and is active against cells expressing the envelope glycoproteins from diverse primate immunodeficiency retroviruses.

Proceedings of the National Academy of Sciences of the United States of America
E A BergerB Moss

Abstract

We previously described an unusual recombinant protein, designated CD4(178)-PE40, containing the gp120 binding region of human CD4 linked to active regions of Pseudomonas exotoxin A. The ability of this molecule to selectively inhibit protein synthesis in cells expressing the surface envelope glycoprotein of human immunodeficiency virus (HIV) suggested this molecule may be useful in treating infected individuals. To further evaluate its therapeutic potential, several in vitro properties of this hybrid toxin were examined. CD4(178)-PE40 was found to be an extremely potent cytotoxic agent, selectively killing HIV-infected cells with IC50 values around 100 pM. In a coculture system employing mixtures of HIV-infected and -uninfected cells, the hybrid toxin inhibited spread of the infection, as judged by a delay in HIV-induced cell killing and a dramatic suppression of free virus production. Experiments with control recombinant proteins indicated that this protective effect was primarily due to selective killing of the HIV-infected cells, rather than to a simple blocking effect of the CD4 moiety of the hybrid toxin. Using recombinant vaccinia viruses as expression vectors, we found the hybrid toxin to be active against cells express...Continue Reading

References

Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G FranchiniR C Gallo
Jan 7, 1988·Nature·R A FisherR T Schooley
Jan 7, 1988·Nature·A TrauneckerK Karjalainen
Mar 11, 1988·Cell·Q J Sattentau, R A Weiss
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·T FolksK Sell
Jul 4, 1986·Cell·J M Coffin
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T R FuerstB Moss
Nov 6, 1986·Journal of Immunological Methods·H TadaK Tsukamoto

❮ Previous
Next ❯

Citations

Jan 1, 1993·Cytotechnology·Y Heike, T Tsuruo
Aug 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J VerhoefH H Balfour
Jan 1, 1993·Toxicon : Official Journal of the International Society on Toxinology·G S HarrisonI Castillo
Jan 11, 1991·Trends in Pharmacological Sciences·S R PettewayB W Metcalf
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·E S DaarD D Ho
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·P AshornE A Berger
Jan 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M WatanabeN L Letvin
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·M WatanabeN L Letvin
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·S H Pincus, J McClure
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·S M SmithK T Jeang
Mar 17, 2004·AIDS Research and Human Retroviruses·Kira K LuedersDean H Hamer
Mar 1, 1992·Antimicrobial Agents and Chemotherapy·K J Connolly, S M Hammer
Jan 15, 2014·PLoS Pathogens·Paul W DentonJ Victor Garcia
Sep 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·E A BergerI Pastan
Dec 1, 1996·Antiviral Research·S H Pincus
May 20, 1998·Journal of Drug Targeting·M G Van Oijen, F W Preijers
Apr 10, 1991·The American Journal of Medicine·E S Daar, D D Ho
Aug 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lakshmi Narashimhan RamanaUma Maheswari Krishnan
Jan 1, 1990·Annals of the New York Academy of Sciences·P AshornE A Berger
Feb 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Seth H PincusWilliam C Olson
Sep 29, 2020·Seminars in Immunology·Adam R WardR Brad Jones
Apr 1, 1995·Clinical Microbiology Reviews·E De Clercq
Jan 1, 1997·Bioconjugate Chemistry·V V TolstikovS H Pincus
Sep 28, 1990·Science·H MitsuyaS Broder
Dec 22, 1989·Science·J Palca

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.